Aptiv Unveils Gen 8 Radars to Power the Future of ADAS
21.10.2025 14:00:00 CEST | Business Wire | Press Release
Aptiv PLC (NYSE: APTV), a global technology company focused on enabling a safer, greener, and more connected future, today announced its most advanced radar technology to date—engineered to meet the evolving demands of future advanced driver-assistance systems (ADAS). Powered by Aptiv’s proprietary antenna and silicon design, the Gen 8 radars deliver the class-leading performance and high-resolution sensing needed to support AI- and machine learning–driven ADAS capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015954076/en/
Aptiv unveils new Gen 8 Radars
Aptiv’s Gen 8 radars unlock new possibilities for hands-free driving in complex urban environments, delivering advanced perception with greater cost efficiency. Both front-facing and corner radar units represent a significant leap forward in how vehicles sense and interpret their surroundings, providing reliable performance even in the most challenging real-world conditions.
The same core IP that powers Aptiv’s Gen 8 radars, also drives the newly launched Aptiv PULSE Sensor—a compact, versatile solution that combines radar and camera data to enhance perception around the entire vehicle. By integrating ultra short-range technology with a surround-view camera, PULSE can replace up to four ultrasonic sensors, improving detection accuracy while reducing system complexity and cost for automakers. Its precision and adaptability make it also ideal for multiple short-range sensing applications, including drones and industrial robotics.
“Aptiv pioneered radar technology in production vehicles more than two decades ago, and today, we’re once again setting the pace,” said Javed Khan, Executive Vice President and President of Software, Advanced Safety and User Experience, Aptiv. “Our Gen 8 Radars mark a major step forward in the journey toward intelligent, software-defined vehicles—delivering all-weather reliability, 4D perception, and deep environmental awareness that enable global automakers to safely and cost-effectively scale to higher levels of automation.”
Expanding the Perception Portfolio
Backed by over 25 years in radar technology expertise, Aptiv’s Gen 8 radars combine proprietary software and hardware intellectual property (IP), introducing significant improvements in performance for a broader range of driving solutions across challenging weather and lighting conditions.
The Gen 8 radars enable new driving scenarios—such as Navigation on Autopilot (NOA)—even in complex, cluttered environments like urban streets and parking structures, thanks to its significantly expanded field of view.
Key Gen 8 radars features include:
- Forward Radar: Provides long-range detection beyond 300 meters with ultra-fine 4D angular resolution, enabling enhanced classification of over- and under-drivable static objects. This next-generation system delivers a 30% performance boost and doubles the vertical field of view compared to its predecessor.
- Dual-Mode Corner Radar: Enhances the previous generation’s industry-leading range performance by increasing the vertical field of view’s (FOV) resolution, delivering improved capability in close-range, low-speed scenarios such as frontal automatic emergency braking (AEB), automated parking, and object avoidance. Compared to the prior generation, horizontal discrimination improved by 25 percent and vertical discrimination is now possible thanks to cutting-edge sensing technology.
Built for the Real-World Performance
Aptiv’s Gen 8 radars set a new standard in ADAS technology, delivering enhanced detection, precision, and adaptability. Designed for real-world driving performance, they offer smarter, safer, and more scalable solutions such as
- Step-Change in Detection Count: The system delivers improvement in object detection compared to prior generations, enabling the identification of more objects with richer sensor feedback.
- Increased Channel Count: The base configuration of Gen 8 radars doubles the number of channels versus its predecessor, enhancing detection and object classification sensitivity while flexibly delivering premium radar performance with minimal design changes.
- Over- and Under-Drivable Static Objects: Superior 4D angular resolution enables radar-only classification of over- and under-drivable static objects, supporting radar-exclusive target detection for advanced cruise control features.
- Superior Accuracy for Target Detection and Tracking: Advanced discrimination capabilities and a low error rate—even in high dynamic range and low signal-to-noise ratio (SNR) environments—enable the detection and tracking of targets that were previously missed.
- Wider Array for Improved Detection Across the Full Field of View: A leading channel count enables outstanding measurement performance across both the vertical and horizontal fields of view, supporting broader and more precise object detection.
- Real-Time Drivable Space Estimation: Accurately maps open lanes, obstacles, and road debris at highway speeds, significantly enhancing situational awareness and driving safety.
- Supports AI-Powered Systems: Delivers continuous, high-quality sensor data to machine learning models, enabling smarter, more adaptive decision-making across all driving conditions and scenarios.
Together, these solutions underscore Aptiv’s commitment to shaping a software-defined future—leveraging AI, machine learning, and sensor fusion to deliver scalable, efficient technologies that can extend beyond automotive to support cross-industries applications.
For more information visit Aptiv’s media site.
About Aptiv
Aptiv is a global technology company that develops safer, greener, and more connected solutions enabling a more sustainable future. Learn more at aptiv.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251015954076/en/
Contacts
Lisa Scalzo
Senior Vice President and Chief Communications Officer
lisa.scalzo@aptiv.com
Ariel Gavilan
Vice President of Global Communications
ariel.gavilan@aptiv.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom